Published in Law and Health Weekly, August 22nd, 2009
During the last 30 years the chemical manufacture of active pharmaceutical ingredients has been undergoing a transition from global pharmaceutical organisations back integrated to commodity chemical raw materials to organisations which focus on their key success drivers and outsource the necessary manufacturing and research support activities. This has required the development of service industries with the necessary skills, facilities and regulatory...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly